Pembrolizumab as maintenance therapy for malignant rhabdoid tumor

Rachel Offenbacher; Lara Fabish; Jennifer Oliver-Krasinski; David M. Loeb; Alissa Baker

doi:10.1002/pbc.29660

Pembrolizumab as maintenance therapy for malignant rhabdoid tumor

Rachel Offenbacher, Lara Fabish, Jennifer Oliver-Krasinski, David M. Loeb, Alissa Baker

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Article number	e29660
Journal	Pediatric Blood and Cancer
Volume	69
Issue number	10
DOIs	https://doi.org/10.1002/pbc.29660
State	Published - Oct 2022

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Hematology
Oncology

Access to Document

10.1002/pbc.29660

Cite this

@article{5faae35d072942cb8fa6c3e890a5b723,

title = "Pembrolizumab as maintenance therapy for malignant rhabdoid tumor",

author = "Rachel Offenbacher and Lara Fabish and Jennifer Oliver-Krasinski and Loeb, {David M.} and Alissa Baker",

year = "2022",

month = oct,

doi = "10.1002/pbc.29660",

language = "English (US)",

volume = "69",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

number = "10",

}

TY - JOUR

T1 - Pembrolizumab as maintenance therapy for malignant rhabdoid tumor

AU - Offenbacher, Rachel

AU - Fabish, Lara

AU - Oliver-Krasinski, Jennifer

AU - Loeb, David M.

AU - Baker, Alissa

PY - 2022/10

Y1 - 2022/10

UR - http://www.scopus.com/inward/record.url?scp=85126016479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85126016479&partnerID=8YFLogxK

U2 - 10.1002/pbc.29660

DO - 10.1002/pbc.29660

M3 - Letter

C2 - 35278029

AN - SCOPUS:85126016479

SN - 1545-5009

VL - 69

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

IS - 10

M1 - e29660

ER -

Pembrolizumab as maintenance therapy for malignant rhabdoid tumor

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this